Proud to share this🔥very first review on chronic #liver diseases in🏳️‍⚧️transgender & gender diverse populations @LancetGastroHep! Highlights: 🔥Hepatic effects of Gender-affirming hormone therapy 🔥CLD in🏳️‍⚧️ 🔥Liver Txp for🏳️‍⚧️ Thanks to my⭐️mentee @ThanhNmed and all the co-authors for their contribution🙏 🆓download authors.elsevier.com/a/1mRR2… #LiverTwitter #GITwitter #LGBTQIA #DEI

📢 Call for public comment now open: #AASLD @AGA_Gastro Guideline on #PrimaryBiliaryCholangitis #PBC This guideline is designed to support individualized treatment decisions by weighing the benefits and harms of available therapies. Your expertise can help strengthen the final guideline. Review the draft and share your feedback by Monday, July 13. 🔗Submit your comments here: bit.ly/4e3ToNs

Congrats to @AmreenDinani on her authorship in @AGA_CGH on a new systematic review and meta-analysis evaluating change in corrected T1 (cT1) following interventions in adults with metabolic dysfunction-associated steatotic liver disease. --> duke.is/z/km34 #MASH #MASLD

📚🩺💡 New #LFNguidelines review! @BlaneyMD Key highlights: 🔹 Diagnosis and evaluation of ascites 🔹 Prevention and management of SBP 🔹 Recognition and treatment of HRS 🔹 Practical, guideline-based clinical pearls Read here ⬇️ 🔗 aasld.org/liver-fellow-netwo…

🏳️‍🌈 Pride Month Reminder: Protect Your Health, Protect Your Community This #PrideMonth, we celebrate love, identity and the power of showing up for ourselves and one another — and that includes our health. 🩺 🔗 hepb.org/prevention-and-diag… #Pride2026

Bookmark 🔖 for rounds and wards! Check out our @LiverFellow ‘Back to Basics’ approach to ascites infographic! SAAG, protein, etiology and pathophys! #VictoriaKusztos @MayoMN_IMRES @mmbilalkhalid @HopkinsGIHep @VCU_Liver Appreciate the shoutout @BlaneyMD!

Do you know that most of the new #ART or💉#PrEP for #HIV no longer cover #HBV⁉️ Read our latest article @CIDJournal :🔥 Don’t Drop the B : #HBV infection/reactivation risk in the era of #tenofovir-sparing #ART & #PrEP 📜pubmed.ncbi.nlm.nih.gov/4220… I will also discuss some of the content at #AASLD 🏳️‍🌈#Pride Webinar, TOMORROW 6/9 noon ET. 🆓🔗liverlearning.aasld.org/Publ… #LiverTwitter #IDTwitter #HBV #HIV

New B Heppy #PODCAST 🎙️Dr. Joseph Lim 👀 In this episode Bright and Anousha sit down with Dr. Joseph Lim, Director of Clinical Hepatology at Yale, to explore the connection between viral hepatitis and MASH/MASLD and what it means for liver health. 🎧 buzzsprout.com/1729790/episo…

AASLD is deeply concerned by the May 29 Executive Order directing a review of U.S. childhood vaccine recommendations, including #hepatitisA and #hepatitisB vaccination policies. Vaccination remains one of the most effective tools for preventing #liverdisease. AASLD strongly supports maintaining evidence-based hepatitis A and hepatitis B vaccination recommendations, which have helped dramatically reduce infections, chronic liver disease, cirrhosis, and liver cancer in the U.S. Protecting children from preventable infectious diseases must remain a national priority. Read our statement: bit.ly/4ckbExT

Join tomorrow’s webinar on HBV screening, vaccination, and how monitoring can be incorporated into care for patients using/considering PrEP use. Register and become an expert on HCV elimination and education strategies in MSM and transgender populations. bit.ly/3RhJFKp

🏆 Four days left to make an impact! The new #AASLD Impact Award honors members making meaningful contributions across research, clinical care, education, mentorship, and innovation, with a clear trajectory toward future leadership in the field. Submit a nomination in less than 10 minutes! Self-nominate or nominate a peer before June 7. 👉 Be part of recognizing excellence across the AASLD community, nominate today: bit.ly/4whA86e.

🆕 research - Liver stiffness dynamics in European populations (LiverScreen): a longitudinal, multicentre, prospective, population-based cohort study thelancet.com/journals/langa… #GITwitter #MedTwitter #LiverTwitter

Happy #PRIDE to all of our 🏳️‍🌈🏳️‍⚧️#LGBTQ physicians, learners, care partners, and patients in Digestive and Liver Health 🫶 #GITwitter #LiverTwitter #Pride2026

Join us for the🌈2026 @AASLDtweets #Pride Webinar:🏳️‍🌈Viral #Hepatitis & Sexual Health in #LGBTQ Communities and Beyond🤗 📅 June 9, Tue 🕛 12:00–1:00 PM EDT ✅ AMA PRA Category 1 Credit🆓 🔗liverlearning.aasld.org/Publ… #LiverTwitter #NoHep #HBV #HCV

During #Pride and every day: LGBTIQ refugee rights are human rights. No exceptions, no compromises, no discrimination.

"My work at the AGA is not work!" Let's give a warm welcome to the 121st president of AGA, @BCryer! Get to know Dr. Cryer and what he's looking forward to in his year as AGA president.

🌈Join @ASGEendoscopy & @RainbowinGastro for a 🆓webinar on applying to GI fellowship and early-career jobs as an #LGBTQ applicant! 📅 Tuesday, June 2nd ⏰ 8 PM ET/7 PM CST 🔗public.asge.org/Public/Event… We hope to see you there! #MedEd #GITwitter #LiverTwitter

📜 From cirrhosis to cACLD through modern diagnostics 🗣️ J. Génesca & P. Hytiroglou Key messages: 🔬 NITs reshaped cACLD — but pathology is NOT dead! ⚠️ Up to 37% with LSM ≥13 kPa have occult cACLD 💡 Clinicopathologic correlation remains key #EASLCongress

BREAKING NEWS: A major milestone for people living with #HepatitisD. The FDA has approved #bulevirtide (#Hepcludex), the first approved treatment for chronic #HDV infection. In this news article, #AASLD member Ira M. Jacobson, MD, FAASLD, highlights the potential of this long-awaited therapy to help address a significant unmet need for people living with HDV. Read more: bit.ly/4u70DJg.

A🌎study of >2500 #cirrhosis inpts➡️no link b/w #rifaximin & drug-resistant #infections Done w #CLEARED consortium 🔑#rifaximin➡️useful for #HE ✅real-world evidence before changing practice! @CMH_journal e-cmh.org/journal/view.php?n… builds on @AGA_Gastro pubmed.ncbi.nlm.nih.gov/4012…

Snaps from the poster session at #DDW2026. Lots of pride for @ashley_jowell and Eghosa Adodo who presented research from STRIVE (Southern Liver Health Study). Mentor: @CindyMoylan_MD. Well done, congrats to all! 👏 #GITwitter @DDWMeeting